Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1993 Sep;68(3):617–620. doi: 10.1038/bjc.1993.396

The absence of Harvey ras mutations during development and progression of squamous cell carcinomas of the head and neck.

L J Clark 1, K Edington 1, I R Swan 1, K A McLay 1, W J Newlands 1, L C Wills 1, H A Young 1, P W Johnston 1, R Mitchell 1, G Robertson 1, et al.
PMCID: PMC1968389  PMID: 8353052

Abstract

We have examined the incidence of Harvey ras mutations in human squamous cell carcinomas (SCC) of the upper aerodigestive tract using the polymerase chain reaction (PCR) followed by direct sequencing. No mutations were detected at codons 12, 13, 59 or 61 of this gene in any of six papillomas, five erythroplakias, 56 squamous cell carcinomas, and 16 SCC cell lines. Some of the SCC were lymph node metastases (three) or tumours which had recurred following radiotherapy (seven). We conclude that Harvey ras mutations are not a common event in the pathogenesis or recurrence of SCCs from Caucasian subjects, in contrast to the situation with Indian populations (Saranath et al., 1991).

Full text

PDF

Images in this article

618Figure 1
on p.618

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alitalo K., Kuismanen E., Myllylä R., Kiistala U., Asko-Seljavaara S., Vaheri A. Extracellular matrix proteins of human epidermal keratinocytes and feeder 3T3 cells. J Cell Biol. 1982 Sep;94(3):497–505. doi: 10.1083/jcb.94.3.497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BOUTWELL R. K. SOME BIOLOGICAL ASPECTS OF SKIN CARCINOGENISIS. Prog Exp Tumor Res. 1964;4:207–250. doi: 10.1159/000385978. [DOI] [PubMed] [Google Scholar]
  3. Balmain A., Ramsden M., Bowden G. T., Smith J. Activation of the mouse cellular Harvey-ras gene in chemically induced benign skin papillomas. Nature. 1984 Feb 16;307(5952):658–660. doi: 10.1038/307658a0. [DOI] [PubMed] [Google Scholar]
  4. Bos J. L. ras oncogenes in human cancer: a review. Cancer Res. 1989 Sep 1;49(17):4682–4689. [PubMed] [Google Scholar]
  5. Brown K., Buchmann A., Balmain A. Carcinogen-induced mutations in the mouse c-Ha-ras gene provide evidence of multiple pathways for tumor progression. Proc Natl Acad Sci U S A. 1990 Jan;87(2):538–542. doi: 10.1073/pnas.87.2.538. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chang S. E., Bhatia P., Johnson N. W., Morgan P. R., McCormick F., Young B., Hiorns L. Ras mutations in United Kingdom examples of oral malignancies are infrequent. Int J Cancer. 1991 May 30;48(3):409–412. doi: 10.1002/ijc.2910480318. [DOI] [PubMed] [Google Scholar]
  7. Clark L. J. Oncogenes and ENT: a review of the molecular biological advances in squamous cell carcinoma of the head and neck. Clin Otolaryngol Allied Sci. 1993 Feb;18(1):4–13. doi: 10.1111/j.1365-2273.1993.tb00801.x. [DOI] [PubMed] [Google Scholar]
  8. Corominas M., Kamino H., Leon J., Pellicer A. Oncogene activation in human benign tumors of the skin (keratoacanthomas): is HRAS involved in differentiation as well as proliferation? Proc Natl Acad Sci U S A. 1989 Aug;86(16):6372–6376. doi: 10.1073/pnas.86.16.6372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Corominas M., Leon J., Kamino H., Cruz-Alvarez M., Novick S. C., Pellicer A. Oncogene involvement in tumor regression: H-ras activation in the rabbit keratoacanthoma model. Oncogene. 1991 Apr;6(4):645–651. [PubMed] [Google Scholar]
  10. Dubeau L., Chandler L. A., Gralow J. R., Nichols P. W., Jones P. A. Southern blot analysis of DNA extracted from formalin-fixed pathology specimens. Cancer Res. 1986 Jun;46(6):2964–2969. [PubMed] [Google Scholar]
  11. Glick A. B., Sporn M. B., Yuspa S. H. Altered regulation of TGF-beta 1 and TGF-alpha in primary keratinocytes and papillomas expressing v-Ha-ras. Mol Carcinog. 1991;4(3):210–219. doi: 10.1002/mc.2940040308. [DOI] [PubMed] [Google Scholar]
  12. Gross-Bellard M., Oudet P., Chambon P. Isolation of high-molecular-weight DNA from mammalian cells. Eur J Biochem. 1973 Jul 2;36(1):32–38. doi: 10.1111/j.1432-1033.1973.tb02881.x. [DOI] [PubMed] [Google Scholar]
  13. Henrard D. R., Thornley A. T., Brown M. L., Rheinwald J. G. Specific effects of ras oncogene expression on the growth and histogenesis of human epidermal keratinocytes. Oncogene. 1990 Apr;5(4):475–481. [PubMed] [Google Scholar]
  14. Hultman T., Bergh S., Moks T., Uhlén M. Bidirectional solid-phase sequencing of in vitro-amplified plasmid DNA. Biotechniques. 1991 Jan;10(1):84–93. [PubMed] [Google Scholar]
  15. Leon J., Kamino H., Steinberg J. J., Pellicer A. H-ras activation in benign and self-regressing skin tumors (keratoacanthomas) in both humans and an animal model system. Mol Cell Biol. 1988 Feb;8(2):786–793. doi: 10.1128/mcb.8.2.786. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ozanne B., Fulton R. J., Kaplan P. L. Kirsten murine sarcoma virus transformed cell lines and a spontaneously transformed rat cell-line produce transforming factors. J Cell Physiol. 1980 Oct;105(1):163–180. doi: 10.1002/jcp.1041050118. [DOI] [PubMed] [Google Scholar]
  17. Paraskeva C., Buckle B. G., Sheer D., Wigley C. B. The isolation and characterization of colorectal epithelial cell lines at different stages in malignant transformation from familial polyposis coli patients. Int J Cancer. 1984 Jul 15;34(1):49–56. doi: 10.1002/ijc.2910340109. [DOI] [PubMed] [Google Scholar]
  18. Parkinson E. K., Newbold R. F. Benzo(a)pyrene metabolism and DNA adduct formation in serially cultivated strains of human epidermal keratinocytes. Int J Cancer. 1980 Sep 15;26(3):289–299. doi: 10.1002/ijc.2910260307. [DOI] [PubMed] [Google Scholar]
  19. Paterson H., Reeves B., Brown R., Hall A., Furth M., Bos J., Jones P., Marshall C. Activated N-ras controls the transformed phenotype of HT1080 human fibrosarcoma cells. Cell. 1987 Dec 4;51(5):803–812. doi: 10.1016/0092-8674(87)90103-6. [DOI] [PubMed] [Google Scholar]
  20. Quintanilla M., Brown K., Ramsden M., Balmain A. Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature. 1986 Jul 3;322(6074):78–80. doi: 10.1038/322078a0. [DOI] [PubMed] [Google Scholar]
  21. Rheinwald J. G., Beckett M. A. Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas. Cancer Res. 1981 May;41(5):1657–1663. [PubMed] [Google Scholar]
  22. Rumsby G., Carter R. L., Gusterson B. A. Low incidence of ras oncogene activation in human squamous cell carcinomas. Br J Cancer. 1990 Mar;61(3):365–368. doi: 10.1038/bjc.1990.80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Sankaranarayanan R. Oral cancer in India: an epidemiologic and clinical review. Oral Surg Oral Med Oral Pathol. 1990 Mar;69(3):325–330. doi: 10.1016/0030-4220(90)90294-3. [DOI] [PubMed] [Google Scholar]
  24. Saranath D., Chang S. E., Bhoite L. T., Panchal R. G., Kerr I. B., Mehta A. R., Johnson N. W., Deo M. G. High frequency mutation in codons 12 and 61 of H-ras oncogene in chewing tobacco-related human oral carcinoma in India. Br J Cancer. 1991 Apr;63(4):573–578. doi: 10.1038/bjc.1991.133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Sheng Z. M., Barrois M., Klijanienko J., Micheau C., Richard J. M., Riou G. Analysis of the c-Ha-ras-1 gene for deletion, mutation, amplification and expression in lymph node metastases of human head and neck carcinomas. Br J Cancer. 1990 Sep;62(3):398–404. doi: 10.1038/bjc.1990.306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Stell P. M. Smoking and laryngeal cancer. Lancet. 1972 Mar 18;1(7751):617–618. doi: 10.1016/s0140-6736(72)90411-4. [DOI] [PubMed] [Google Scholar]
  27. Tabin C. J., Bradley S. M., Bargmann C. I., Weinberg R. A., Papageorge A. G., Scolnick E. M., Dhar R., Lowy D. R., Chang E. H. Mechanism of activation of a human oncogene. Nature. 1982 Nov 11;300(5888):143–149. doi: 10.1038/300143a0. [DOI] [PubMed] [Google Scholar]
  28. Winton D. J., Blount M. A., Ponder B. A. Polyclonal origin of mouse skin papillomas. Br J Cancer. 1989 Jul;60(1):59–63. doi: 10.1038/bjc.1989.220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Yeudall W. A., Torrance L. K., Elsegood K. A., Speight P., Scully C., Prime S. S. Ras gene point mutation is a rare event in premalignant tissues and malignant cells and tissues from oral mucosal lesions. Eur J Cancer B Oral Oncol. 1993 Jan;29B(1):63–67. doi: 10.1016/0964-1955(93)90012-4. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES